The above results complied with the detected results of clinical blood samples, such that the expression of ERCC5 and RORA was significantly down‐regulated in CAD patients compared to those of the normal group in blood samples (Fig. 10D,F), whereas HES6 expression was up‐regulated (Fig. 10E). The gene discussed is RORA; the disease is coronary artery disorder.